Mucosal immunology research continues its fascination with microbial metabolites. In 2019, researchers uncovered extended functions for microbial metabolites in immunity, deepening our understanding of the regulation and function of metabolite-reactive immune cells, and revealed the receptors by which immune cells can recognize bioactive microbial metabolites.
Key advances
Short-chain fatty acids affect host defence by acting on group 3 innate lymphoid cells via free fatty acid receptor 2 (FFAR2), on macrophages through metabolic reprogramming and on memory CD8+ T cells through an FFAR2-dependent and FFAR3-dependent shift in T cell metabolism.
Screens have revealed microbial metabolites that activate G protein-coupled receptors (GPCRs) affecting numerous host physiological processes.
Mucosal-associated invariant T (MAIT) cells rely on early life bacterial exposures for their development, and skin-resident MAIT cells play crucial roles in tissue repair.
Effective mining of public resources of microbial metabolites, GPCR–metabolite interactions and immune cell transcriptomes is accelerating the pace of discovery and translation of immune–microbial metabolite interactions for promoting health and mitigating disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
npj Biofilms and Microbiomes Open Access 20 December 2023
-
Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy
Nature Communications Open Access 09 March 2023
-
Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration
Microbiome Open Access 20 May 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chun, E. et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity https://doi.org/10.1016/j.immuni.2019.09.014 (2019).
Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity 51, 285–297 (2019).
Schulthess, J. et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50, 432–445 (2019).
Skelly, A. N. et al. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat. Rev. Immunol. 19, 305–323 (2019).
Morita, N. et al. GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. Nature 566, 110–114 (2019).
Colosimo, D. A. et al. Mapping interactions of microbial metabolites with human G-protein-coupled receptors. Cell Host Microbe 26, 273–282.e7 (2019).
Chen, H. et al. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell 177, 1217–1231 (2019).
Constantinides, M. G. et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science 366, eaax6624 (2019).
Legoux, F. et al. Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science 366, 494–499 (2019).
Godfrey, D. I. et al. The biology and functional importance of MAIT cells. Nat. Immunol. 20, 1110–1128 (2019).
Acknowledgements
The author thanks members of the Garrett laboratory for stimulating discussions. Work related to this piece is supported by the US National Institutes of Health (R01CA154426 and R24DK11049).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author is a member of the scientific advisory boards of Kintai Therapeutics, Leap Therapeutics, Evelo Biosciences and Tenza.
Additional information
RELATED LINK
Human Microbiome Bioactives Resource (HMBR): https://www.microbiome-bioactives.org/
Rights and permissions
About this article
Cite this article
Garrett, W.S. Immune recognition of microbial metabolites. Nat Rev Immunol 20, 91–92 (2020). https://doi.org/10.1038/s41577-019-0252-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-019-0252-2
This article is cited by
-
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
npj Biofilms and Microbiomes (2023)
-
Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy
Nature Communications (2023)
-
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial
Nature Medicine (2022)
-
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms
Nature Reviews Immunology (2022)
-
Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration
Microbiome (2021)